Evidence map›Paper›PMID 42122978›Full record

ArticleJournal of clinical medicine2026

Efficacy and Safety of Vilaprisan in the Treatment of Uterine Fibroids: Data from ASTEROID 5, a Phase 3 Multicenter Randomized Controlled Trial.

K Gemzell-Danielsson, C-H Cho, P Vadász, R Wenzl, L Dong, T Faustmann, E Groettrup-Wolfers, K Laapas, S Parke, C Haberland and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

K Gemzell-DanielssonDepartment of Women's and Children's Health, Karolinska Institutet, 171 77 Stockholm, Sweden.ORCID 0000-0001-6516-1444
C-H ChoDepartment of Obstetrics and Gynecology, School of Medicine, Keimyung University, Daegu 42601, Republic of Korea.
P VadászDepartment of Obstetrics and Gynecology, Selye János Hospital, 2900 Komárom, Hungary.
R WenzlDepartment of Obstetrics and Gynecology, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0001-6177-1421
L DongBayer AG, 13353 Berlin, Germany.ORCID 0009-0004-7965-5997
T FaustmannBayer AG, 13353 Berlin, Germany.
E Groettrup-WolfersBayer AG, 13353 Berlin, Germany.
K LaapasBayer Oy, 02100 Espoo, Finland.
S ParkeBayer AG, 13353 Berlin, Germany.
C HaberlandBayer AG, 13353 Berlin, Germany.
C SeitzBayer AG, 13353 Berlin, Germany.ORCID 0000-0003-2315-9148

Funding

Bayer AG, Berlin, Germany NA
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

amenorrheaheavy menstrual bleedingselective progesterone receptor modulatoruterine fibroidsvilaprisan

Identifiers

PMID42122978
PMCPMC13164208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.